Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1632
This examiner grants 64% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19361182 | METHODS AND COMPOSITIONS FOR PRODUCING GRANULOSA-LIKE CELLS | Non-Final OA | President and Fellows of Harvard College |
| 16341508 | UNDIFFERENTIATED STEM CELL-REMOVING AGENT, AND METHOD FOR REMOVING UNDIFFERENTIATED STEM CELLS | Non-Final OA | KEIO UNIVERSITY |
| 17040246 | METHOD FOR REPROGRAMMING SOMATIC CELLS | Non-Final OA | UNIVERSITE CLAUDE BERNARD LYON 1 |
| 18161546 | METHODS OF DIFFERENTIATION TO NEURONAL CELLS AND KITS THEREFOR | Final Rejection | LIFE TECHNOLOGIES CORPORATION |
| 17226642 | Hematopoietic Stem and Progenitor Cell Expansion System | Final Rejection | LIFE TECHNOLOGIES CORPORATION |
| 17756386 | CAR T CELLS WITH ENHANCED METABOLIC FITNESS | Final Rejection | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC. |
| 18488859 | TREATMENT OF CANAVAN DISEASE | Non-Final OA | CITY OF HOPE |
| 17833506 | METHOD FOR CULTURING MYOGENIC CELLS, CULTURES OBTAINED THEREFROM, SCREENING METHODS, AND CELL CULTURE MEDIUM | Non-Final OA | Erasmus University Medical Center Rotterdam |
| 18415477 | ARTIFICIAL NUCLEIC ACID MOLECULES | Final Rejection | CureVac SE |
| 17759574 | tRNA OVEREXPRESSION AS A THERAPEUTIC APPROACH FOR CHARCOT-MARIE-TOOTH NEUROPATHY ASSOCIATED WITH MUTATIONS IN tRNA SYNTHETASES | Final Rejection | Stichting Radboud Universiteit |
| 18508761 | NUCLEIC ACID CONSTRUCTS ENCODING REPROGRAMMING FACTORS LINKED BY SELF-CLEAVING PEPTIDES | Non-Final OA | Whitehead Institute of Biomedical Research |
| 18504238 | METHODS OF PRODUCING HUMAN RPE CELLS AND PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS | Final Rejection | Astellas Institute for Regenerative Medicine |
| 18502249 | COMPOSITIONS AND METHODS FOR PRODUCING NON-HUMAN TISSUE ENGINEERED MEAT PRODUCTS | Non-Final OA | MYOS CORP. |
| 17045412 | COMPOSITIONS AND METHODS FOR SOMATIC CELL REPROGRAMMING AND MODULATING IMPRINTING | Final Rejection | Children's Medical Center Corporation |
| 18550232 | METHOD FOR OBTAINING TUMOR-HYPOXIA EDUCATED REGENERATIVE MACROPHAGES AND USE THEREOF IN REGENERATIVE MEDICINE | Final Rejection | HUMANITAS MIRASOLE S.P.A. |
| 18456148 | HUMAN IPSC-BASED DERIVATION OF NK AND T-CELLS USING EARLY NOTCH INDUCTION | Non-Final OA | BOSTON MEDICAL CENTER CORPORATION |
| 18361571 | GENE THERAPY VECTORS FOR TREATING HEART DISEASE | Non-Final OA | Tenaya Therapeutics, Inc. |
| 18074272 | DORSALLY-DERIVED OLIGODENDROCYTE PROGENITOR CELLS FROM HUMAN PLURIPOTENT STEM CELLS | Final Rejection | Asterias Biotherapeutics, Inc. |
| 18259588 | HUMAN SCALP HAIR FOLLICLE SINGLE CELL SUSPENSION, PREPARATION METHOD AND APPLICATION THEREOF | Non-Final OA | SHANGHAI ICURE BIOSCIENCE CO., LTD |
| 18332823 | METHODS OF INCREASING GROWTH OF CORALS USING A BIOCERAMIC | Non-Final OA | NOVUM CORAL, INC. |
| 18012840 | BIFUNCTIONAL BRIDGING COMPOSITIONS FOR VIRAL TRANSDUCTION | Non-Final OA | Lycia Therapeutics, Inc. |
| 17672254 | METHODS FOR ANALYZING TUMOR INNATE IMMUNE INTERACTIONS USING THE ZEBRAFISH XENOGRAFT MODEL AS A LIVING BIOMARKER | Final Rejection | Fundaçâo D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud |
| 17542992 | METHODS FOR DETECTING AND MODULATING THE EMBRYONIC-FETAL TRANSITION IN MAMMALIAN SPECIES | Non-Final OA | AgeX Therapeutics, Inc. |
| 17264029 | A METHOD OF GENERATING STERILE AND MONOSEX PROGENY | Non-Final OA | Center for Aquaculture Technologies, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy